Stock Ticker

  • Loading stock data...

pSivida Corp. (NASDAQ:PSDV) Elects Veteran Healthcare Executive To Its Board

pSivida Corp. (NASDAQ:PSDV) reported that it has elected Kristine Peterson, who is a seasoned healthcare executive, to its Board of Directors. Peterson has extensive pharma experience, having worked as the CEO of Valeritas from 2009 to 2016, a commercial-stage medical technology firm focused on simplifying life and improving health for people with diabetes. She has […]

Heat Biologics Inc (NASDAQ:HTBX) Appoints Dr. Jeff Hutchins As New Chief Operating Officer

Heat Biologics Inc (NASDAQ:HTBX) has appointed Dr. Jeff Hutchins as its Chief Operating Officer. Dr. Hutchins was previously CSO and SVP, Pre-clinical Development with the company. In his new role, he will lead product development initiatives for Heat Biologic and its Pelican Therapeutics subsidiary firm. The management view Jeff Wolf, the CEO of Heat Biologics, […]

Bristol-Myers Squibb Co (NYSE:BMY)’s Opdivo A Death Call For Chemotherapy

Boston, MA 09/29/2014 (wallstreetpr) – As per a Reuters report, Bristol-Myers Squibb Co (NYSE:BMY) has taken another shot to the success. The drug maker has achieved another important milestone with its immunotherapy drug, Opdivo. As per a new melanoma study, the drug had reported an increased and imporved response rate complemented by fewer side effects […]

Pfizer Inc. (NYSE:PFE) And Bristol-Myers Squibb Co (NYSE:BMY) Announced FDA Clearance For Eliquis For Blood Clots Treatment

Boston, MA 08/22/2214 (wallstreetpr) – Pfizer Inc. (NYSE:PFE) and Bristol-Myers Squibb Co (NYSE:BMY) announced recently that the USFDA has given an extension of approving Eliquis, the blood thinner, which shall be used for the treatment of fatal blood clots. The treatment of two kinds of blood clots can be done by way of this blood […]

Bristol-Myers Squibb Co (NYSE:BMY): Wins The Case Against Pennsylvania

Boston, MA 06/20/2014 (wallstreetpr) – It is the time for celebration for Bristol-Myers Squibb Co (NYSE:BMY) as it has won a case against Pennsylvania. Now it doesn’t need to pay $28 million for the drug pricing dispute to Pennsylvania. Bristol-Myers was sued by Pennsylvania in the year 2004. It was alleged for inflating the wholesale […]

Bristol-Myers Squibb Co (NYSE:BMY) Posts Positive Q3 Results

Boston, MA 10/24/2013 (wallstreetpr) – The New York based BioPharma company Bristol-Myers Squibb Co (NYSE:BMY) posted its Q3 results of this fiscal year. The results were in sync with happy tunes revealing a 9% increase in sales that resulted in $4.1 billion. Its profits of $692 million were more than what the trade analysts had estimated. […]

Sign Up To Get Our Latest Stocks Alerts